Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Case Reports of Untoward Drug Reactions, Adverse Events, and Rare Diseases

Case Reports of Untoward Drug Reactions, Adverse Events, and Rare Diseases Abstract The problem is a shortage of page space. Only a small number of the case reports submitted to scientific medical periodicals can be accepted for publication. Most editorial boards attach the highest priority to reports of clinical investigations in a consecutive series of patients. Editorial responsibility for publication of data from clinical trials and other multiple-subject studies limits space for single-case studies. This shortage of page space grows more serious as the volume of excellent research increases throughout the world. Although we recognize the educational merits of a carefully described case study, the editorial board members of this periodical can justify publication of case reports only if these data establish new principles or modify currently accepted concepts. There is no longer room for the description of the "sixth case" of a new syndrome, and we experience a similar inability to publish every report of adverse drug reactions. Problems related to References 1. Oliver MF: Risks of correcting the risks of coronary disease and stroke with drugs. N Engl J Med 1982;306:297-298.Crossref 2. Gifford LM, Aeugle ME, Myerson RM, et al: Cimetidine postmarket outpatient surveillance program. JAMA 1980; 243:1532-1533.Crossref 3. Davis TG, Pickett DL, Schlosser JH: Evaluation of a worldwide spontaneous reporting system with cimetidine. JAMA 1980;243:1912-1913.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Case Reports of Untoward Drug Reactions, Adverse Events, and Rare Diseases

Archives of Internal Medicine , Volume 142 (7) – Jul 1, 1982

Loading next page...
 
/lp/american-medical-association/case-reports-of-untoward-drug-reactions-adverse-events-and-rare-1adVNcaYiQ
Publisher
American Medical Association
Copyright
Copyright © 1982 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1982.00340200029007
Publisher site
See Article on Publisher Site

Abstract

Abstract The problem is a shortage of page space. Only a small number of the case reports submitted to scientific medical periodicals can be accepted for publication. Most editorial boards attach the highest priority to reports of clinical investigations in a consecutive series of patients. Editorial responsibility for publication of data from clinical trials and other multiple-subject studies limits space for single-case studies. This shortage of page space grows more serious as the volume of excellent research increases throughout the world. Although we recognize the educational merits of a carefully described case study, the editorial board members of this periodical can justify publication of case reports only if these data establish new principles or modify currently accepted concepts. There is no longer room for the description of the "sixth case" of a new syndrome, and we experience a similar inability to publish every report of adverse drug reactions. Problems related to References 1. Oliver MF: Risks of correcting the risks of coronary disease and stroke with drugs. N Engl J Med 1982;306:297-298.Crossref 2. Gifford LM, Aeugle ME, Myerson RM, et al: Cimetidine postmarket outpatient surveillance program. JAMA 1980; 243:1532-1533.Crossref 3. Davis TG, Pickett DL, Schlosser JH: Evaluation of a worldwide spontaneous reporting system with cimetidine. JAMA 1980;243:1912-1913.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Jul 1, 1982

References